Pneumonia News and Research

Latest Pneumonia News and Research

Acute lung injury patients one-third less likely to die in 'closed' model ICUs

Patients with acute lung injury (ALI) are nearly one-third less likely to die if they are treated at ICUs that require board-certified critical care physicians to oversee patient care, as compared to patients treated at ICUs that allow any attending physician to oversee admission and case management.

29 Sep 2007

U.S. hospitals report infections increasing in frequency and cost

A new review of inpatient data from US hospitals shows that the number of infections caused by a common bacterium increased by over 7 percent each year from 1998 to 2003.

26 Sep 2007

Care by a hospital-based general physician strongly associated with shorter length of hospital stay in patients

Patients at an academic medical center who are cared for by a hospital-based general physician may have a shorter length of hospital stay than those who are not, especially if the patients require close monitoring or complex discharge planning, according to a report in the September 24 issue of Archives of Internal Medicine.

25 Sep 2007

Social cheating in bacterial communication

Baseball had its steroids and Black Sox. Politics lived through Watergate. Wall Street has been riddled with insider trading scandals. And before we cast the first stone, who among us has never tried to get through an intersection on a yellow light?

25 Sep 2007

Cases of invasive pneumococcal disease in children reduced

The number of cases of invasive pneumococcal disease (IPD) in children has fallen since the introduction of a new vaccine a year ago. Enhanced surveillance by the UK's Health Protection Agency has shown that cases of IPD caused by the seven major types of the pneumococcus bacteria which the new pneumococcal conjugate vaccine (PCV) protects against have gone down by almost 50%.

20 Sep 2007

Discovery of cause of Job's syndrome

The rare immunodeficiency disorder known as Job's syndrome is caused by a specific genetic mutation that both overstimulates and understimulates the human immune system, leading to harmful bacterial and fungal infections and the physical features characteristic of the syndrome, according to two independent groups of scientists, one from the National Institutes of Health (NIH) and the other from the Tokyo Medical and Dental University.

20 Sep 2007

Pregnancy may slow AIDS progression

A new study may help put to rest fears that pregnancy accelerates progression to full-blown AIDS in women with HIV receiving antiretroviral therapy.

20 Sep 2007

Moxifloxacin drug combo speeds up treatment of tuberculosis

A team of tuberculosis (TB) experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four.

18 Sep 2007

Global child deaths have reached a record low

Global child deaths have reached a record low, falling below 10 million per year to 9.7 million, down from almost 13 million in 1990, according to UNICEF.

13 Sep 2007

Secondhand smoke affects pets too

The threat of secondhand smoke to the health of non-smokers has been known for years but now researchers say pets can also suffer from the effects of secondhand smoke.

5 Sep 2007

Secondhand smoke and pets

It has been in the news for years about how secondhand smoke is a health threat to nonsmokers. The Center for Disease Control and Prevention indicates that secondhand smoke is attributed with killing thousands of adult nonsmokers annually.

3 Sep 2007

New targets for antibiotics

University of Illinois at Chicago researchers have identified new sites on the bacterial cell's protein-making machinery where antibiotics can be delivered to treat infections.

30 Aug 2007

New understanding of what makes a major global bacterial infection deadly

Researchers believe they have discovered why a bacterial lung infection is so lethal in the early stages, and it's not what medical authorities had thought, according to research published in the journal Immunity.

28 Aug 2007

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

24 Aug 2007

Environmental tests help predict hospital-acquired Legionnaires' disease risk

A new study spearheaded by the University of Pittsburgh School of Medicine has determined that environmental monitoring of institutional water systems can help to predict the risk of hospital-acquired Legionella pneumonia, better known as Legionnaires disease.

24 Aug 2007

Breakthrough for Huntington's disease

A major breakthrough in the understanding and potential treatment of Huntington's disease has been made by scientists at the University of Leeds.

24 Aug 2007

Bali hit by bird flu again

There has been another death from bird flu in Bali; this time the victim is a 28-year-old woman.

22 Aug 2007

Improving the quality of primary care could prevent 4 million hospitalizations each year

More than 4 million hospitalizations potentially could be prevented each year by improving the quality of primary care, enhancing patients' access to effective treatments, and getting more Americans to adopt healthy behaviors, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

13 Aug 2007

Legionnaires' disease in Surrey with links to Institute of Animal Health at Pirbright

The Health Protection Agency can confirm that its Surrey Health Protection Unit is involved in an investigation with the Health and Safety Executive and local environmental health officers of a reported case of Legionnaires' disease with alleged links to the Institute of Animal Health at Pirbright, in Surrey .

12 Aug 2007

GSK receives FDA 'not approvable letter' for Advair for COPD

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).

9 Aug 2007